These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16835288)

  • 1. Cerebral degeneration predicts survival in amyotrophic lateral sclerosis.
    Kalra S; Vitale A; Cashman NR; Genge A; Arnold DL
    J Neurol Neurosurg Psychiatry; 2006 Nov; 77(11):1253-5. PubMed ID: 16835288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.
    Pohl C; Block W; Karitzky J; Träber F; Schmidt S; Grothe C; Lamerichs R; Schild H; Klockgether T
    Arch Neurol; 2001 May; 58(5):729-35. PubMed ID: 11346367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.
    Rule RR; Suhy J; Schuff N; Gelinas DF; Miller RG; Weiner MW
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):141-9. PubMed ID: 15512902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis.
    Pyra T; Hui B; Hanstock C; Concha L; Wong JC; Beaulieu C; Johnston W; Kalra S
    Amyotroph Lateral Scler; 2010; 11(1-2):157-65. PubMed ID: 19242831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.
    Rooney WD; Miller RG; Gelinas D; Schuff N; Maudsley AA; Weiner MW
    Neurology; 1998 Jun; 50(6):1800-5. PubMed ID: 9633731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.
    Suhy J; Miller RG; Rule R; Schuff N; Licht J; Dronsky V; Gelinas D; Maudsley AA; Weiner MW
    Neurology; 2002 Mar; 58(5):773-9. PubMed ID: 11889242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy.
    Kalra S; Hanstock CC; Martin WR; Allen PS; Johnston WS
    Arch Neurol; 2006 Aug; 63(8):1144-8. PubMed ID: 16908742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of diffusion tensor imaging or magnetic resonance spectroscopy in the diagnosis and disability assessment of amyotrophic lateral sclerosis.
    Liu C; Jiang R; Yi X; Zhu W; Bu B
    J Neurol Sci; 2015 Jan; 348(1-2):206-10. PubMed ID: 25524526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS.
    de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Ojeda I; Martínez A; Gil C; Arahuetes RM
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):243-255. PubMed ID: 23688553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting neuronal dysfunction of hand motor cortex in ALS: A MRSI study.
    Wang Y; Li X; Chen W; Wang Z; Xu Y; Luo J; Lin H; Sun G
    Somatosens Mot Res; 2017 Mar; 34(1):15-20. PubMed ID: 28114839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of creatine supplementation on metabolite levels in ALS motor cortices.
    Vielhaber S; Kaufmann J; Kanowski M; Sailer M; Feistner H; Tempelmann C; Elger CE; Heinze HJ; Kunz WS
    Exp Neurol; 2001 Dec; 172(2):377-82. PubMed ID: 11716561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T.
    Wang S; Poptani H; Woo JH; Desiderio LM; Elman LB; McCluskey LF; Krejza J; Melhem ER
    Radiology; 2006 Jun; 239(3):831-8. PubMed ID: 16641339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
    Mitsumoto H; Ulug AM; Pullman SL; Gooch CL; Chan S; Tang MX; Mao X; Hays AP; Floyd AG; Battista V; Montes J; Hayes S; Dashnaw S; Kaufmann P; Gordon PH; Hirsch J; Levin B; Rowland LP; Shungu DC
    Neurology; 2007 Apr; 68(17):1402-10. PubMed ID: 17452585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degeneration of the mid-cingulate cortex in amyotrophic lateral sclerosis detected in vivo with MR spectroscopy.
    Sudharshan N; Hanstock C; Hui B; Pyra T; Johnston W; Kalra S
    AJNR Am J Neuroradiol; 2011 Feb; 32(2):403-7. PubMed ID: 21087934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral Sclerosis: A Prospective Multicenter Study.
    Ta D; Ishaque A; Srivastava O; Hanstock C; Seres P; Eurich DT; Luk C; Briemberg H; Frayne R; Genge AL; Graham SJ; Korngut L; Zinman L; Kalra S
    Neurology; 2021 Aug; 97(8):e803-e813. PubMed ID: 34426551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis.
    Abe K; Takanashi M; Watanabe Y; Tanaka H; Fujita N; Hirabuki N; Yanagihara T
    Neuroradiology; 2001 Jul; 43(7):537-41. PubMed ID: 11512581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings.
    Ellis CM; Simmons A; Andrews C; Dawson JM; Williams SC; Leigh PN
    Neurology; 1998 Oct; 51(4):1104-9. PubMed ID: 9781537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy.
    Kalra S; Cashman NR; Genge A; Arnold DL
    Neuroreport; 1998 Jun; 9(8):1757-61. PubMed ID: 9665596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ratio of N-acetyl aspartate to glutamate correlates with disease duration of amyotrophic lateral sclerosis.
    Sako W; Abe T; Izumi Y; Harada M; Kaji R
    J Clin Neurosci; 2016 May; 27():110-3. PubMed ID: 26765768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results.
    Kalra S; Genge A; Arnold DL
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):22-6. PubMed ID: 12745614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.